DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Reteplase
Reteplase
Spontaneous Epidural Hematoma of the Cervical Spine Following Thrombolysis in a Patient with STEMI—Two Medical Specialties Facing a Rare Dilemma
Full Prescribing Information for - Active Internal Bleeding (4) RETAVASE
Dosing and Administration Guide for RETAVASE® (Reteplase) for Injection1
Best Evidence for Antithrombotic Agent Reversal in Bleeding
In Vivo Effects of Contrast Media on Coronary Thrombolysis
Use of Antithrombotic Medications in the Presence of Neuraxial Anesthesia
Update in Standard of Care for Venous Thromboembolism from the June 2012 Supplement to CHEST and 2017 AC Forum
Summary of Product Characteristics, Labelling and Package Leaflet
Venothrombotic Events: the Subtle Killer Disclosure Statement
Stembook 2018.Pdf
Protocol for Non-Interventional Studies Based on Existing Data TITLE PAGE Document Number: C30445781-01
Life Threatening Massive Pulmonary Embolism Treated with Reteplase: a Case Report
680 Letters to the Editor Anatol J Cardiol 2015; 15: 676-81
(Reteplase, Tenecteplase) – HEP Rpa/Tnk and Adjunctive Heparin
Anticoagulation Reversal in the Hemorrhagic Stroke Patient
ANTICOAGULATION RELATED BLEEDING - GUIDELINE SUMMARY Click Here for the Full Thrombosis Prevention Investigation and Management of Anticoagulation Guideline
RETAVASE- Reteplase Chiesi USA, Inc.
Newer Anticoagulants/ Antiplatelets and Patient Teaching
Top View
Fight Night! a 2021 Stroke Debate
Thrombolysis with Reteplase in Acute Pulmonary Embolism
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
* Thromboembolic Disease Antithrombotic Therapy for Venous
Antithrombotic Therapy in Patients with Acute Coronary Syndromes
Evaluation of Efficacy and Safety of Reteplase and Alteplase in The
Statistics on Medicines Consumption 2009
Effects of Reteplase and Alteplase on Platelet Aggregation and Major Receptor Expression During the First 24 Hours of Acute Myocardial Infarction Treatment
Therapeutic Effect Evaluation of Reteplase on Acute Pulmonary Embolism
Rapilysin, INN-Reteplase
Drug Repositioning and Indication Discovery Using Description Logics
Lovenox EMEA-H-A-30-1429
Rapilysin, INN-Reteplase
HEPARIN SODIUM 100 I.U./Ml FLUSHING SOLUTION for MAINTENANCE of PATENCY of INTRAVENOUS DEVICES
In-AMI Trial
ANTICOAGULANT, THROMBOLYTIC, and ANTI-PLATELET DRUGS
Guidelines for ATC Classification and DDD Assignment 2021
Anticoagulants: the Quick Guide to Use and Reversal
Effect of Low-Dose Intracoronary Alteplase During Primary
2020 Table of Drugs
(EDL) and a Licensed Drugs List (LDL) for Afghanistan
Guideline for Reversal of Antithrombotics in Intracranial
Enoxaparin Sodium Injection Full Prescribing Information
Guidelines for ATC Classification and DDD Assignment 2013
Pulmonary Thromboembolism (1 of 16)
Identification of Potential Drug Targets Based on a Computational Biology Algorithm for Venous Thromboembolism
HIGH-ALERT MEDICATIONS High-Alert Medications Are Drugs That Bear a Heightened Risk of Causing Significant Patient Harm When They Are Used in Error
Rapilysin, INN-Reteplase
CPMP 24 to 26 July 2001 Plenary Meeting
Cardio Exam 4 Cheat Sheet by Kfisher17
Auspar Attachment 1: Product Information for Enoxaparin Sodium
Lovenox Safely and • Effectively
Product Monograph
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
ISMP List of High-Alert Medications in Acute Care Settings
Overview of Reteplase, a Novel Thrombolytic Agent in Indian Context
Ticagrelor Vs Clopidogrel After Fibrinolytic Therapy in Patients with ST-Elevation Myocardial Infarction: a Randomized Clinical Trial